231 related articles for article (PubMed ID: 29854319)
1. Circulating miRNAs as biomarkers in diffuse large B-cell lymphoma: a systematic review.
Lopez-Santillan M; Larrabeiti-Etxebarria A; Arzuaga-Mendez J; Lopez-Lopez E; Garcia-Orad A
Oncotarget; 2018 Apr; 9(32):22850-22861. PubMed ID: 29854319
[TBL] [Abstract][Full Text] [Related]
2. Systematic Review of the Potential of MicroRNAs in Diffuse Large B Cell Lymphoma.
Larrabeiti-Etxebarria A; Lopez-Santillan M; Santos-Zorrozua B; Lopez-Lopez E; Garcia-Orad A
Cancers (Basel); 2019 Jan; 11(2):. PubMed ID: 30691158
[TBL] [Abstract][Full Text] [Related]
3. Serum miR-22 as potential non-invasive predictor of poor clinical outcome in newly diagnosed, uniformly treated patients with diffuse large B-cell lymphoma: an explorative pilot study.
Marchesi F; Regazzo G; Palombi F; Terrenato I; Sacconi A; Spagnuolo M; Donzelli S; Marino M; Ercolani C; Di Benedetto A; Blandino G; Ciliberto G; Mengarelli A; Rizzo MG
J Exp Clin Cancer Res; 2018 May; 37(1):95. PubMed ID: 29716630
[TBL] [Abstract][Full Text] [Related]
4. The Roles of Exosomal microRNAs in Diffuse Large B-Cell Lymphoma: Diagnosis, Prognosis, Clinical Application, and Biomolecular Mechanisms.
Yazdanparast S; Huang Z; Keramat S; Izadirad M; Li YD; Bo L; Gharehbaghian A; Chen ZS
Front Oncol; 2022; 12():904637. PubMed ID: 35719983
[TBL] [Abstract][Full Text] [Related]
5. Circulating RNA biomarkers in diffuse large B-cell lymphoma: a systematic review.
Decruyenaere P; Offner F; Vandesompele J
Exp Hematol Oncol; 2021 Feb; 10(1):13. PubMed ID: 33593440
[TBL] [Abstract][Full Text] [Related]
6. MicroRNAs as novel biomarkers in diffuse large B-cell lymphoma--a systematic review.
Jørgensen LK; Poulsen MØ; Laursen MB; Marques SC; Johnsen HE; Bøgsted M; Dybkær K
Dan Med J; 2015 May; 62(5):. PubMed ID: 26050834
[TBL] [Abstract][Full Text] [Related]
7. microRNA sequencing for biomarker detection in the diagnosis, classification and prognosis of Diffuse Large B Cell Lymphoma.
Larrabeiti-Etxebarria A; Bilbao-Aldaiturriaga N; Arzuaga-Mendez J; Martin-Arruti M; Cozzuto L; Gaafar A; Ruiz-Diaz I; Guerra I; Martin-Guerrero I; Lopez-Lopez E; Gutierrez-Camino A
Sci Rep; 2023 Jul; 13(1):12159. PubMed ID: 37500691
[TBL] [Abstract][Full Text] [Related]
8. Circulating microRNA-125b and microRNA-130a expression profiles predict chemoresistance to R-CHOP in diffuse large B-cell lymphoma patients.
Yuan WX; Gui YX; Na WN; Chao J; Yang X
Oncol Lett; 2016 Jan; 11(1):423-432. PubMed ID: 26870228
[TBL] [Abstract][Full Text] [Related]
9. miR-199a and miR-497 Are Associated with Better Overall Survival due to Increased Chemosensitivity in Diffuse Large B-Cell Lymphoma Patients.
Troppan K; Wenzl K; Pichler M; Pursche B; Schwarzenbacher D; Feichtinger J; Thallinger GG; Beham-Schmid C; Neumeister P; Deutsch A
Int J Mol Sci; 2015 Aug; 16(8):18077-95. PubMed ID: 26251897
[TBL] [Abstract][Full Text] [Related]
10. Circulating cell-free miR-494 and miR-21 are disease response biomarkers associated with interim-positron emission tomography response in patients with diffuse large B-cell lymphoma.
Cui Q; Vari F; Cristino AS; Salomon C; Rice GE; Sabdia MB; Guanzon D; Palma C; Mathew M; Talaulikar D; Jain S; Han E; Hertzberg MS; Gould C; Crooks P; Thillaiyampalam G; Keane C; Gandhi MK
Oncotarget; 2018 Oct; 9(78):34644-34657. PubMed ID: 30410665
[TBL] [Abstract][Full Text] [Related]
11. Comprehensive miRNA sequence analysis reveals survival differences in diffuse large B-cell lymphoma patients.
Lim EL; Trinh DL; Scott DW; Chu A; Krzywinski M; Zhao Y; Robertson AG; Mungall AJ; Schein J; Boyle M; Mottok A; Ennishi D; Johnson NA; Steidl C; Connors JM; Morin RD; Gascoyne RD; Marra MA
Genome Biol; 2015 Jan; 16(1):18. PubMed ID: 25723320
[TBL] [Abstract][Full Text] [Related]
12. Discovery and validation of immune-associated long non-coding RNA biomarkers associated with clinically molecular subtype and prognosis in diffuse large B cell lymphoma.
Zhou M; Zhao H; Xu W; Bao S; Cheng L; Sun J
Mol Cancer; 2017 Jan; 16(1):16. PubMed ID: 28103885
[TBL] [Abstract][Full Text] [Related]
13. High miR-34a expression improves response to doxorubicin in diffuse large B-cell lymphoma.
Marques SC; Ranjbar B; Laursen MB; Falgreen S; Bilgrau AE; Bødker JS; Jørgensen LK; Primo MN; Schmitz A; Ettrup MS; Johnsen HE; Bøgsted M; Mikkelsen JG; Dybkær K
Exp Hematol; 2016 Apr; 44(4):238-46.e2. PubMed ID: 26854484
[TBL] [Abstract][Full Text] [Related]
14. Serum microRNAs are promising novel biomarkers for diffuse large B cell lymphoma.
Fang C; Zhu DX; Dong HJ; Zhou ZJ; Wang YH; Liu L; Fan L; Miao KR; Liu P; Xu W; Li JY
Ann Hematol; 2012 Apr; 91(4):553-9. PubMed ID: 21987025
[TBL] [Abstract][Full Text] [Related]
15. Serum microRNA expression profiling predict response to R-CHOP treatment in diffuse large B cell lymphoma patients.
Song G; Gu L; Li J; Tang Z; Liu H; Chen B; Sun X; He B; Pan Y; Wang S; Cho WC
Ann Hematol; 2014 Oct; 93(10):1735-43. PubMed ID: 24858372
[TBL] [Abstract][Full Text] [Related]
16. Peripheral Blood Cells from Patients with Hodgkin's and Diffuse Large B Cell Lymphomas May Be a Better Source of Candidate Diagnostic miRNAs Than Circulating miRNAs.
Paszkiewicz-Kozik E; Paziewska A; Kulecka M; Dąbrowska M; Kluska A; Bałabas A; Piątkowska M; Ambrożkiewicz F; Tajer J; Osiadacz W; Romejko-Jarosińska J; Kotarska M; Żeber-Lubecka N; Karczmarski J; Popławska L; Mikula M; Rutkowski P; Walewski J; Ostrowski J
Biomed Res Int; 2021; 2021():3212878. PubMed ID: 33628777
[TBL] [Abstract][Full Text] [Related]
17. MicroRNA as potential biomarker in HCV-associated diffuse large B-cell lymphoma.
Augello C; Gianelli U; Savi F; Moro A; Bonoldi E; Gambacorta M; Vaira V; Baldini L; Bosari S
J Clin Pathol; 2014 Aug; 67(8):697-701. PubMed ID: 24914240
[TBL] [Abstract][Full Text] [Related]
18. Dysregulated MicroRNA Expression Profiles and Potential Cellular, Circulating and Polymorphic Biomarkers in Non-Hodgkin Lymphoma.
Bradshaw G; Sutherland HG; Haupt LM; Griffiths LR
Genes (Basel); 2016 Dec; 7(12):. PubMed ID: 27999330
[TBL] [Abstract][Full Text] [Related]
19. Dysregulation of miRNAs in DLBCL: Causative Factor for Pathogenesis, Diagnosis and Prognosis.
Alsaadi M; Khan MY; Dalhat MH; Bahashwan S; Khan MU; Albar A; Almehdar H; Qadri I
Diagnostics (Basel); 2021 Sep; 11(10):. PubMed ID: 34679437
[TBL] [Abstract][Full Text] [Related]
20. Circulating MicroRNAs as Biomarkers in Diffuse Large B-cell Lymphoma: A Pilot Prospective Longitudinal Clinical Study.
Bouvy C; Wannez A; George F; Graux C; Chatelain C; Dogné JM
Biomark Cancer; 2018; 10():1179299X18781095. PubMed ID: 29977116
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
